<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170816</url>
  </required_header>
  <id_info>
    <org_study_id>80576354-050-99/167</org_study_id>
    <nct_id>NCT04170816</nct_id>
  </id_info>
  <brief_title>Dry Needling With And Without Kinesio Taping® in The Non-Specific Chronic Low Back Pain</brief_title>
  <official_title>Comparing Dry Needling With And Without Kinesio Taping® in The Treatment of Non-Specific Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kars State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kars State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wiil evaluate the efficiency of adding kinesio taping (KT) therapy to dry needling (DN)
      therapy on pain, functionality and depression parameters in 60 patients with nonspecific
      chronic low back pain (nCLBP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 60 patients will be included in the study. 30 patients will be in the treatment
      group and 30 patients will be in the control group. Both groups will be underwent 3 sessions
      with 1-week intervals on active myofascial trigger points in lumbar multifidus, quadratus
      lumborum and gluteus medius muscles in DN therapy. KT application will be performed after
      every DN session in the study group. Pain will evaluate with visual analog scale,
      functionality was evaluated with Oswestry Disability Index and the status of depression will
      be evaluated with Beck Depression Index before the treatment and at the first month.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain pressure threshold</measure>
    <time_frame>3 week</time_frame>
    <description>Amount of pressure (Kg/cm2) applied at the lomber multifidus muscle, quadratus lumborum and gluteus medius muscle myofascial trigger point site that elicit pain for the patient will be reported</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain by visual analog scale (VAS)</measure>
    <time_frame>3 week</time_frame>
    <description>Visual analog scale (VAS,0-10) will be used to assess resting, activity and night pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry disability Index (ODI)</measure>
    <time_frame>3 week</time_frame>
    <description>Changes from the Baseline, ODI is an effective tool to provide information on the extent of backache affecting the patient ability to cope with tasks of everyday life. Ten sections are included in the ODI tool with a total possible score of 5 for each section. The first statement carries a score of 0, and the last has a score of 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>3 week</time_frame>
    <description>This is a 21-item standard assessment used to measure clinical depression. Scores on this assessment range from 0 to 63, where higher scores indicate higher levels of depression.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Non-Spesific Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>DN plus KT group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DN plus KT therapy is going to be applied 3 sessions in 1-week intervals. Dry Needling Theraphy: DN therapy is going to be applied on active myofascial trigger points (MTrP) in quadratus lumborum, gluteus medius and lumbar multifidus muscles.
Kinesio Taping Application: Tapes is going to be left on the patient's body for 5 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DN group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DN will be applied 3 sessions in 1-week intervals. Dry Needling Theraphy: DN therapy was applied on active myofascial trigger points (MTrP) in quadratus lumborum, gluteus medius and lumbar multifidus muscles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dry needling</intervention_name>
    <description>DN and KT therapy will be applied 3 sessions in 1-week intervals</description>
    <arm_group_label>DN group</arm_group_label>
    <arm_group_label>DN plus KT group</arm_group_label>
    <other_name>Kinesiotape</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  having no abnormal results in routine blood tests

          -  having no known acute or chronic inflammatory disease

          -  an education level required for understanding the applied treatment, interventions

        Exclusion Criteria:

          -  malignancies

          -  active infection

          -  history of common inflammatory rheumatic disease

          -  trauma in spinal area, skin lesion, presence of infection or open wounds

          -  radiculopathy

          -  peripheral circulation disorder

          -  use of warfarin due to coagulopathy

          -  arthropathy

          -  congenital or acquired spinal pathology

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kars State Hospital</investigator_affiliation>
    <investigator_full_name>Fatih Bagcier</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Dry needling</keyword>
  <keyword>Kinesiotape</keyword>
  <keyword>Low-back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

